17 alpha-hydroxylase deficiency other diagnostic studies
Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
17 alpha-hydroxylase deficiency other diagnostic studies On the Web |
American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency other diagnostic studies |
FDA on 17 alpha-hydroxylase deficiency other diagnostic studies |
CDC on 17 alpha-hydroxylase deficiency other diagnostic studies |
17 alpha-hydroxylase deficiency other diagnostic studies in the news |
Blogs on 17 alpha-hydroxylase deficiency other diagnostic studies |
Risk calculators and risk factors for 17 alpha-hydroxylase deficiency other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Immunohistochemical staining of the adrenal gland may be used for the diagnosis of congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency and it demonstrates hyperplasia, poorly defined zone borders, and intermingling of the chromaffin and cortical cells.
Other Diagnostic Studies
- Immunohistochemical staining of the adrenal gland may be used in patients with 17 alpha-hydroxylase deficiency and it demonstrates:
- Poorly defined zone borders
- Intermingling of the chromaffin and cortical cells
- Amniotic fluid 11-deoxycortisol and oligonucleotide hybridization of deoxyribonucleic acid (DNA) obtained from chorionic villus biopsies
- DNA analysis[1]
References
- ↑ Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency. Wikipedia (2016. https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_17_alpha-hydroxylase_deficiency Accessed on February 4, 2016